Coronavirus 2019 Disease (COVID-19), Systemic Inflammation, and Cardiovascular Disease

Affiliations

¹ Institute of Cardiology Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health University of Brescia Italy.
² Cardiovascular Division Brigham and Women's Hospital, and Harvard Medical School Boston MA.
³ Division of Preventive Medicine Center for Cardiovascular Disease Prevention Brigham and Women's Hospital, and Harvard Medical School Boston MA.

Comment

Riccardo M Inciardi et al. J Am Heart Assoc. 2020.

. 2020 Aug 18;9(16):e017756.

doi: 10.1161/JAHA.120.017756. Epub 2020 Jul 17.

¹ Institute of Cardiology Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health University of Brescia Italy.
² Cardiovascular Division Brigham and Women's Hospital, and Harvard Medical School Boston MA.
³ Division of Preventive Medicine Center for Cardiovascular Disease Prevention Brigham and Women's Hospital, and Harvard Medical School Boston MA.

No abstract available

Keywords: COVID‐19; heart failure; immunomodulation; vascular inflammation.

Conflict of interest statement

None.

Clinical characteristics of COVID-19 infection in chronic obstructive pulmonary disease: a multicenter, retrospective, observational study.
Wu F, Zhou Y, Wang Z, Xie M, Shi Z, Tang Z, Li X, Li X, Lei C, Li Y, Ni Z, Hu Y, Liu X, Yin W, Cheng L, Ye F, Peng J, Huang L, Tian J, Zhang L, Mo X, Zhang Y, Hu K, Jiang Y, Guan W, Xiang J, Liu Y, Peng Y, Wei L, Hu Y, Peng P, Wang J, Liu J, Huang W, Chen R, Zhao J, Li S, Zhang N, Zhao J, Zhong N, Ran P; Medical Treatment Expert Group for COPD and COVID-19. Wu F, et al. J Thorac Dis. 2020 May;12(5):1811-1823. doi: 10.21037/jtd-20-1914. J Thorac Dis. 2020. PMID: 32642086 Free PMC article.

1. World Health Organization . Pneumonia of unknown 15 cause—China. Available at: https://www.who.int/csr/don/05-january-2020-17pneumonia-of-unknown-c.... Accessed January 5, 2020.
1. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui D, et al.; China Medical Treatment 16 Expert Group for COVID‐19 . Clinical characteristics of 17 coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708–1720. - PMC - PubMed
1. Siddiqu HK, Mehra MR. COVID‐19 illness in native and immunosuppressed states: a clinicaltherapeutic staging proposal. J Heart Lung Transplant. 2020;39:405–407. - PMC - PubMed
1. Inciardi RM, Adamo M, Lupi L, Cani DS, Di Pasquale M, Tomasoni D, Italia L, Zaccone G, Tedino C, Fabbricatore D, et al. Characteristics and outcomes of patients hospitalized for COVID‐19 and cardiac disease in Northern Italy. Eur Heart J. 2020;41:1821–1829. - PMC - PubMed
1. Inciardi RM, Lupi L, Zaccone G, Italia L, Raffo M, Tomasoni D, Cani DS, Cerini M, Farina D, Gavazzi E, et al. Cardiac involvement in a patient with coronavirus 2019 (COVID‐19). JAMA Cardiol. 2020;5:1–6. - PMC - PubMed